Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecord History now reflects an updated page version, with Revision: v3.6.5 listed instead of v3.6.4. This indicates the study record has been refreshed to a new version in ClinicalTrials.gov.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe footer shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a new site update in the page's revision history.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision tag v3.6.3 is added to the history and the v3.6.2 entry is removed. This reflects a minor update to the page version in the study record history and does not change the underlying study data or content shown to users.SummaryDifference0.0%

- Check53 days agoChange DetectedThe record history now shows a newer revision entry (v3.6.2). The older revision (v3.6.0) has been removed from the list.SummaryDifference0.0%

- Check67 days agoChange DetectedRecruitment status changed to 'no longer looking for participants.' The record revision was updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history now shows Revision: v3.5.5 replacing the previous v3.5.4, indicating a minor site update.SummaryDifference0.0%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.